SELLAS Life Sciences Group (SLS) Competitors $1.89 +0.13 (+7.39%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$1.92 +0.03 (+1.32%) As of 05/23/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SLS vs. VECT, SION, KROS, IMTX, TYRA, VALN, MRVI, RLAY, GHRS, and STOKShould you be buying SELLAS Life Sciences Group stock or one of its competitors? The main competitors of SELLAS Life Sciences Group include VectivBio (VECT), Sionna Therapeutics (SION), Keros Therapeutics (KROS), Immatics (IMTX), Tyra Biosciences (TYRA), Valneva (VALN), Maravai LifeSciences (MRVI), Relay Therapeutics (RLAY), GH Research (GHRS), and Stoke Therapeutics (STOK). These companies are all part of the "pharmaceutical products" industry. SELLAS Life Sciences Group vs. VectivBio Sionna Therapeutics Keros Therapeutics Immatics Tyra Biosciences Valneva Maravai LifeSciences Relay Therapeutics GH Research Stoke Therapeutics VectivBio (NASDAQ:VECT) and SELLAS Life Sciences Group (NASDAQ:SLS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, media sentiment, earnings, analyst recommendations, profitability, risk and community ranking. Is VECT or SLS more profitable? VectivBio's return on equity of 0.00% beat SELLAS Life Sciences Group's return on equity.Company Net Margins Return on Equity Return on Assets VectivBioN/A N/A N/A SELLAS Life Sciences Group N/A -629.46%-178.65% Do insiders & institutionals have more ownership in VECT or SLS? 17.4% of SELLAS Life Sciences Group shares are held by institutional investors. 9.7% of VectivBio shares are held by insiders. Comparatively, 1.4% of SELLAS Life Sciences Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has preferable earnings and valuation, VECT or SLS? SELLAS Life Sciences Group has lower revenue, but higher earnings than VectivBio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVectivBio$27.34M20.97-$93.74MN/AN/ASELLAS Life Sciences Group$1M188.58-$37.34M-$0.38-4.97 Does the media favor VECT or SLS? In the previous week, SELLAS Life Sciences Group had 1 more articles in the media than VectivBio. MarketBeat recorded 1 mentions for SELLAS Life Sciences Group and 0 mentions for VectivBio. SELLAS Life Sciences Group's average media sentiment score of 0.49 beat VectivBio's score of 0.00 indicating that SELLAS Life Sciences Group is being referred to more favorably in the news media. Company Overall Sentiment VectivBio Neutral SELLAS Life Sciences Group Neutral Which has more volatility & risk, VECT or SLS? VectivBio has a beta of 0.11, indicating that its share price is 89% less volatile than the S&P 500. Comparatively, SELLAS Life Sciences Group has a beta of 2.34, indicating that its share price is 134% more volatile than the S&P 500. Does the MarketBeat Community favor VECT or SLS? VectivBio and SELLAS Life Sciences Group both received 10 outperform votes by MarketBeat users. However, 55.56% of users gave SELLAS Life Sciences Group an outperform vote while only 43.48% of users gave VectivBio an outperform vote. CompanyUnderperformOutperformVectivBioOutperform Votes1043.48% Underperform Votes1356.52% SELLAS Life Sciences GroupOutperform Votes1055.56% Underperform Votes844.44% SummarySELLAS Life Sciences Group beats VectivBio on 7 of the 11 factors compared between the two stocks. Get SELLAS Life Sciences Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SLS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SLS vs. The Competition Export to ExcelMetricSELLAS Life Sciences GroupPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$188.58M$6.47B$5.33B$8.31BDividend YieldN/A2.64%5.20%4.10%P/E Ratio-2.748.4026.7219.60Price / Sales188.58258.84395.56135.05Price / CashN/A65.8538.3234.62Price / Book-7.566.416.764.50Net Income-$37.34M$143.73M$3.23B$248.40M7 Day Performance15.95%0.27%0.37%-1.03%1 Month Performance41.04%0.09%7.04%7.94%1 Year Performance35.00%0.30%18.61%8.50% SELLAS Life Sciences Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SLSSELLAS Life Sciences Group0.2363 of 5 stars$1.89+7.4%N/A+40.0%$188.58M$1M-2.7410High Trading VolumeVECTVectivBioN/A$16.85flatN/AN/A$573.24M$27.34M0.0030High Trading VolumeSIONSionna TherapeuticsN/A$12.90+4.7%$38.50+198.4%N/A$569.20MN/A0.0035News CoverageAnalyst DowngradeKROSKeros Therapeutics3.2569 of 5 stars$13.74+0.7%$37.00+169.3%-70.4%$558.05M$214.71M-2.64100IMTXImmatics2.6767 of 5 stars$4.56+7.5%$16.67+265.5%-48.0%$554.27M$155.84M-6.91260News CoveragePositive NewsAnalyst DowngradeGap UpTYRATyra Biosciences1.6443 of 5 stars$10.26+1.7%$30.83+200.5%-45.4%$544.70MN/A-6.3720News CoveragePositive NewsAnalyst ForecastAnalyst RevisionGap DownVALNValneva2.0861 of 5 stars$6.45-0.3%$15.50+140.3%-28.2%$539.45M$169.58M-49.62700MRVIMaravai LifeSciences3.9769 of 5 stars$2.12+7.1%$6.34+199.2%-79.4%$539.19M$259.19M-1.29610RLAYRelay Therapeutics3.1783 of 5 stars$3.11+3.7%$17.67+468.1%-58.3%$533.19M$7.68M-1.19330Positive NewsGHRSGH Research2.3973 of 5 stars$10.16-2.1%$30.43+199.5%-16.2%$528.60MN/A-12.8610Analyst DowngradeSTOKStoke Therapeutics3.4586 of 5 stars$9.66+3.2%$25.60+165.0%-36.4%$527.41M$36.56M-4.60100 Related Companies and Tools Related Companies VectivBio Alternatives Sionna Therapeutics Alternatives Keros Therapeutics Alternatives Immatics Alternatives Tyra Biosciences Alternatives Valneva Alternatives Maravai LifeSciences Alternatives Relay Therapeutics Alternatives GH Research Alternatives Stoke Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SLS) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersMarket chaos is the new normalIt happened again. Wall Street swung like a wrecking ball after Trump paused tariffs on smartphones, lapto...Augusta Precious Metals | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMemorial Day Sale! 82% Off Disruptors and Dominators!Jensen Huang recently gave the keynote speech at the Consumer Electronics Show in Las Vegas. When the Nvidi...Weiss Ratings | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SELLAS Life Sciences Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SELLAS Life Sciences Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
